Company
Century Therapeutics, Inc. (IPSC)
Standardized SEC financial data for Century Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001850119 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-15.8%
Net margin
-8.8%
Revenue growth (YoY)
1556.8%
Return on equity
-6.0%
ROIC
-12.3%
Free cash flow
-$104.7M
Debt / equity
0.11×
Current ratio
5.97×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $5.2M | $2.2M | $6.6M | $109.2M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $27.7M | $58.2M | $86.2M | $49.3M | $61.2M | $65.0M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$41.3M | -$89.0M | $14.1M | -$88.3M | -$110.1M | -$103.9M |
| Capital expenditures |
Get IPSC data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/IPSC/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/IPSC/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"